Skip to content
healthcare.dev
Get a free key

DILTIAZEM HYDROCHLORIDE

NDC 50228-495, diltiazem hydrochloride, tablet, extended release, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-495
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-495 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE120 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
50228-495-0550228049505500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-495-05)
50228-495-305022804953030 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-495-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1ca03c9e-edc8-4c7f-89ee-f2346ea8c067

Use it

Look up 50228-495 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-495 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.